Insights

Strategic US Expansion Zealand Pharma's recent investment in expanding its research facilities to Cambridge, Massachusetts indicates a strategic focus on increasing its presence and capabilities in North America. This presents an opportunity to offer tailored solutions for their US operations, such as data management, research collaborations, or laboratory technologies.

Innovative Collaboration Models The company's strategic alliances, including partnerships with Roche, Boehringer Ingelheim, DCAI, and OTR Therapeutics, highlight a strong openness to collaborative innovation in metabolic diseases and obesity treatments. Engaging with their partner networks and offering complementary technologies or joint development platforms could unlock new sales avenues.

Funding and Growth Potential Receiving significant financing of $1.5 billion and having an active pipeline with multiple candidates in clinical phases demonstrate Zealand Pharma's robust growth potential. This financial backing can support the adoption of advanced analytics, AI tools, and other tech solutions to accelerate drug discovery and development.

Focus on Metabolic Health With a dedicated Metabolic Frontier 2030 strategy and pipeline targeting obesity and related metabolic diseases, there is a clear market opportunity to introduce solutions that enhance research efficiency, clinical trial management, and patient engagement within the metabolic health sector.

Tech-Driven R&D Zealand Pharma utilizes a broad technology stack including Power BI, Microsoft Azure, and AI partnerships, indicating a tech-savvy approach to research and development. Offering innovative data solutions, AI integration, or cloud-based platforms could align well with their digital transformation goals.

Zealand Pharma Tech Stack

Zealand Pharma uses 8 technology products and services including Power BI, SOLIDWORKS, Cookiebot, and more. Explore Zealand Pharma's tech stack below.

  • Power BI
    Business Intelligence
  • SOLIDWORKS
    Cad & Graphics
  • Cookiebot
    Cookie Compliance
  • SQL
    Database
  • OneDrive
    File Sharing
  • Microsoft Azure
    Platform As A Service
  • Android
    Programming Languages
  • Adobe Creative Suite
    Visualisation Software

Media & News

Zealand Pharma's Email Address Formats

Zealand Pharma uses at least 1 format(s):
Zealand Pharma Email FormatsExamplePercentage
FLast@zealandpharma.comJDoe@zealandpharma.com
77%
First.Last@zealandpharma.comJohn.Doe@zealandpharma.com
14%
FL@zealandpharma.comJD@zealandpharma.com
5%
FMLast@zealandpharma.comJMDoe@zealandpharma.com
4%

Frequently Asked Questions

Where is Zealand Pharma's headquarters located?

Minus sign iconPlus sign icon
Zealand Pharma's main headquarters is located at 11 Sydmarken Søborg, Hovedstaden 2860 Denmark. The company has employees across 2 continents, including EuropeNorth America.

What is Zealand Pharma's phone number?

Minus sign iconPlus sign icon
You can contact Zealand Pharma's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Zealand Pharma's stock symbol?

Minus sign iconPlus sign icon
Zealand Pharma is a publicly traded company; the company's stock symbol is ZEAL.

What is Zealand Pharma's official website and social media links?

Minus sign iconPlus sign icon
Zealand Pharma's official website is zealandpharma.com and has social profiles on LinkedInCrunchbase.

What is Zealand Pharma's SIC code NAICS code?

Minus sign iconPlus sign icon
Zealand Pharma's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Zealand Pharma have currently?

Minus sign iconPlus sign icon
As of March 2026, Zealand Pharma has approximately 564 employees across 2 continents, including EuropeNorth America. Key team members include Chief Commercial Officer: E. C.Chief Scientific Officer: U. S.Chief Financial Officer: H. W.. Explore Zealand Pharma's employee directory with LeadIQ.

What industry does Zealand Pharma belong to?

Minus sign iconPlus sign icon
Zealand Pharma operates in the Biotechnology Research industry.

What technology does Zealand Pharma use?

Minus sign iconPlus sign icon
Zealand Pharma's tech stack includes Power BISOLIDWORKSCookiebotSQLOneDriveMicrosoft AzureAndroidAdobe Creative Suite.

What is Zealand Pharma's email format?

Minus sign iconPlus sign icon
Zealand Pharma's email format typically follows the pattern of FLast@zealandpharma.com. Find more Zealand Pharma email formats with LeadIQ.

How much funding has Zealand Pharma raised to date?

Minus sign iconPlus sign icon
As of March 2026, Zealand Pharma has raised $4.1M in funding. The last funding round occurred on Jun 06, 2025 for $4.1M.

When was Zealand Pharma founded?

Minus sign iconPlus sign icon
Zealand Pharma was founded in 1998.

Zealand Pharma

Biotechnology ResearchHovedstaden, Denmark501-1000 Employees

At Zealand Pharma, we are a Danish biotechnology company on a mission to change lives with next generation peptide medicines.

In our effort to reach our goals, bonding is at the core of everything we do. Let it be discovering and developing the best new peptide drugs for patients, engaging with partners or connecting with each other.

Ten drug candidates invented by Zealand Pharma have advanced into clinical development, of which two have reached the market. Our current pipeline of internal product candidates focuses on obesity, chronic inflammation, and certain rare diseases.

Our leading obesity programs are backed by strong partners, including Roche and Boehringer Ingelheim.

We are based in Copenhagen (Søborg), Denmark, with a team in the U.S. For further information about our business and activities, please visit www.zealandpharma.com or bond with us through LinkedIn.

Section iconCompany Overview

Headquarters
11 Sydmarken Søborg, Hovedstaden 2860 Denmark
Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
ZEAL
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1998
Employees
501-1000

Section iconFunding & Financials

  • $4.1M

    Zealand Pharma has raised a total of $4.1M of funding over 8 rounds. Their latest funding round was raised on Jun 06, 2025 in the amount of $4.1M.

  • $25M$50M

    Zealand Pharma's revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $4.1M

    Zealand Pharma has raised a total of $4.1M of funding over 8 rounds. Their latest funding round was raised on Jun 06, 2025 in the amount of $4.1M.

  • $25M$50M

    Zealand Pharma's revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.